News
A direct-to-consumer program for its drugs could bring down higher U.S. drug prices while cutting out pharmacy benefit managers.
Roche (OTCQX:RHHBY) (OTCQX:RHHBF) announced Thursday it has begun discussions with the U.S. government to launch ...
Pfizer is cutting costs, growing its core business, and trading at a deep discount despite looming patent losses and COVID ...
Roche is considering selling its prescription medicines in the U.S. directly to consumers to lower costs for patients as part ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results